Overview

Phase 2 Herniorrhaphy Study for Opioid Elimination

Status:
Completed
Trial end date:
2018-12-15
Target enrollment:
Participant gender:
Summary
This is a Phase 2, open-label study in subjects undergoing unilateral open inguinal herniorrhaphy.
Phase:
Phase 2
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Acetaminophen
Ibuprofen
Ketorolac